Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Balaji Amines's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil. Balaji Amines's Total Assets for the quarter that ended in Jun. 2026 was ₹0 Mil.
The historical rank and industry rank for Balaji Amines's Equity-to-Asset or its related term are showing as below:
NSE:BALAMINES'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55 Med: 0.7 Max: 0.82
Current: 0.72
During the past 13 years, the highest Equity to Asset Ratio of Balaji Amines was 0.82. The lowest was 0.55. And the median was 0.70.
NSE:BALAMINES's Equity-to-Asset is ranked better than 70.63% of 1614
companies
in the Chemicals industry
Industry Median: 0.6
vs NSE:BALAMINES: 0.72
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Balaji Amines Equity-to-Asset Related Terms
Balaji Amines Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Balaji Amines's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:BALAMINES vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, Balaji Amines's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balaji Amines Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balaji Amines's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Balaji Amines's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Balaji Amines's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balaji Amines (NSE:BALAMINES) has a Equity-to-Asset of 0.00 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Balaji Amines and its competitors. Over the past decade, Balaji Amines' Equity-to-Asset has ranged from 0.55 to 0.82. According to the industry distribution chart, Balaji Amines ranks #474 out of 1614 companies in the Chemicals industry, placing it in the top 29.4%.
Is Balaji Amines' Equity-to-Asset too high?
Balaji Amines' current Equity-to-Asset is 0.00. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 0.82. Based on the distribution chart, Balaji Amines ranks #474 out of 1614 companies in the Chemicals industry, which is above the industry midpoint. Overall, Balaji Amines has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Balaji Amines ranks #474 out of 1614 companies for Equity-to-Asset. This puts Balaji Amines in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Historically, Balaji Amines' own Equity-to-Asset has ranged from 0.55 to 0.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,614 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Balaji Amines and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balaji Amines's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,828.16, compared to a current price of ₹2,103.70 — trading 15.1% above its estimated fair value. The current Equity-to-Asset is 0.00. Balaji Amines' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Equity-to-Asset is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?
Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued.
The current stock price of ₹2,103.70 is trading 15.1% above its estimated GF Value™ of ₹1,828.16.
GuruFocus considers Balaji Amines to be Modestly Overvalued.
Key valuation signals for NSE:BALAMINES:
Equity-to-Asset: 0.00
GF Value™: ₹1,828.16 vs. price of ₹2,103.70 (15.1% above fair value)
No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
81GF Score
Get the complete analysis for NSE:BALAMINES
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BALAMINES has been successfully added to your 
